- Home
- HCWB vs EVGN Comparison
HCWB vs EVGN Comparison
Compare HCWB & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- EVGN
- Stock Information
- Founded
- HCWB 2018
- EVGN 1999
- Country
- HCWB United States
- EVGN Israel
- Employees
- HCWB N/A
- EVGN N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- EVGN Agricultural Chemicals
- Sector
- HCWB Health Care
- EVGN Industrials
- Exchange
- HCWB Nasdaq
- EVGN Nasdaq
- Market Cap
- HCWB 10.8M
- EVGN 11.6M
- IPO Year
- HCWB 2021
- EVGN N/A
- Fundamental
- Price
- HCWB $5.59
- EVGN $1.27
- Analyst Decision
- HCWB Strong Buy
- EVGN Strong Buy
- Analyst Count
- HCWB 1
- EVGN 1
- Target Price
- HCWB $35.00
- EVGN $3.50
- AVG Volume (30 Days)
- HCWB 5.7M
- EVGN 46.1K
- Earning Date
- HCWB 08-18-2025
- EVGN 08-19-2025
- Dividend Yield
- HCWB N/A
- EVGN N/A
- EPS Growth
- HCWB N/A
- EVGN N/A
- EPS
- HCWB N/A
- EVGN N/A
- Revenue
- HCWB $832,841.00
- EVGN $9,444,000.00
- Revenue This Year
- HCWB $178.36
- EVGN N/A
- Revenue Next Year
- HCWB N/A
- EVGN $63.64
- P/E Ratio
- HCWB N/A
- EVGN N/A
- Revenue Growth
- HCWB N/A
- EVGN N/A
- 52 Week Low
- HCWB $2.77
- EVGN $0.95
- 52 Week High
- HCWB $100.80
- EVGN $3.32
- Technical
- Relative Strength Index (RSI)
- HCWB 60.31
- EVGN 50.50
- Support Level
- HCWB $3.25
- EVGN $1.21
- Resistance Level
- HCWB $6.66
- EVGN $1.31
- Average True Range (ATR)
- HCWB 0.77
- EVGN 0.06
- MACD
- HCWB -0.05
- EVGN 0.00
- Stochastic Oscillator
- HCWB 57.07
- EVGN 64.71
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.